Bioxytran (BIXT) Intangibles (2020 - 2026)
Bioxytran (BIXT) recorded Intangibles of $156,009 in Q2 2026, up 8.1% from $144,357 a year earlier and up 2.5% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Intangibles (2020 - 2026) Analysis & Trends
At the end of FY2025, Bioxytran reported Intangibles of $145,087, up 8.6% from FY2024.
- Annual Intangibles has increased for five straight years, with a five-year compound annual growth rate of 70.7% (FY2020 to FY2025).
- Across earlier years, Intangibles came in at $133,540 in FY2024 (+17.9%), $113,296 in FY2023 (+50.0%), $75,535 in FY2022 (+60.9%) and $46,932 in FY2021 (+369.3%).
- The Q2 2026 figure is the highest quarterly Intangibles in data going back to Q4 2020.
- On a year-over-year basis, Intangibles has increased for three consecutive quarters, with growth averaging 14.9% over the last six quarters.
- The year-over-year growth in Intangibles has ranged between 8.1% (Q2 2026) and 369.3% (Q4 2021) over the last five years.
- Per Business Quant, the preceding three quarters came in at $152,206 (Q1 2026), $145,087 (Q4 2025) and $141,795 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | 156,009.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 156,009.00 |
| Mar 31, 2026 | 152,206.00 |
| Dec 31, 2025 | 145,087.00 |
| Sep 30, 2025 | 141,795.00 |
| Jun 30, 2025 | 144,357.00 |
| Mar 31, 2025 | 131,704.00 |
| Dec 31, 2024 | 133,540.00 |
| Jun 30, 2024 | 115,031.00 |
| Mar 31, 2024 | 115,516.00 |
| Dec 31, 2023 | 113,296.00 |
| Sep 30, 2023 | 108,770.00 |
| Jun 30, 2023 | 97,880.00 |
| Mar 31, 2023 | 79,732.00 |
| Dec 31, 2022 | 75,535.00 |
| Sep 30, 2022 | 74,349.00 |
| Jun 30, 2022 | 67,548.00 |
| Mar 31, 2022 | 68,343.00 |
| Dec 31, 2021 | 46,932.00 |
| Sep 30, 2021 | 18,954.00 |
| Jun 30, 2021 | 18,954.00 |
API Access
Bioxytran Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();